Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
The objective of the present study was to clarify the mechanism by which the sulfonylurea drug, glibenclamide, inhibits single CFTR channels in excised patches from Xenopus oocytes. Glibenclamide blocks the open pore of the channel via binding at multiple sites with varying kinetics. In the absence of glibenclamide, open-channel bursts exhibited a flickery intraburst closed state (C1); this is due to block of the pore by the pH buffer, TES. Application of 25 microM glibenclamide to the cytoplasmic solution resulted in the appearance of two drug-induced intraburst closed states (C2, C3) of widely different duration, which differed in pH-dependence. The kinetics of interaction with the C3 state, but not the C2 state, were strongly voltage-dependent. The durations of both the C2 and C3 states were concentration-dependent, indicating a non-linear reaction scheme. Application of drug also increased the burst duration, which is consistent with an open-channel blocking mechanism. A kinetic model is proposed. These results indicate that glibenclamide interacts with open CFTR channels in a complex manner, involving interactions with multiple binding sites in the channel pore.
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995, Pubmed
Aguilar-Bryan,
Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.
1995,
Pubmed Anderson,
Generation of cAMP-activated chloride currents by expression of CFTR.
1991,
Pubmed Ashfield,
Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel.
1999,
Pubmed
,
Xenbase Babenko,
The tolbutamide site of SUR1 and a mechanism for its functional coupling to K(ATP) channel closure.
1999,
Pubmed Bear,
Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).
1992,
Pubmed Cai,
Inhibition of heterologously expressed cystic fibrosis transmembrane conductance regulator Cl- channels by non-sulphonylurea hypoglycaemic agents.
1999,
Pubmed Cai,
Voltage-dependent gating of the cystic fibrosis transmembrane conductance regulator Cl- channel.
2003,
Pubmed Fischer,
CFTR displays voltage dependence and two gating modes during stimulation.
1994,
Pubmed Giblin,
The cytoplasmic C-terminus of the sulfonylurea receptor is important for KATP channel function but is not key for complex assembly or trafficking.
2002,
Pubmed Golstein,
P-glycoprotein inhibition by glibenclamide and related compounds.
1999,
Pubmed Gupta,
Point mutations in the pore region directly or indirectly affect glibenclamide block of the CFTR chloride channel.
2002,
Pubmed Hanrahan,
Inhibition of an outwardly rectifying anion channel by HEPES and related buffers.
1990,
Pubmed Haws,
CFTR channels in immortalized human airway cells.
1992,
Pubmed Ishihara,
Block by MOPS reveals a conformation change in the CFTR pore produced by ATP hydrolysis.
1997,
Pubmed Julien,
Cystic fibrosis transmembrane conductance regulator (CFTR) confers glibenclamide sensitivity to outwardly rectifying chloride channel (ORCC) in Hi-5 insect cells.
1999,
Pubmed Linsdell,
Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a mammalian cell line and its regulation by a critical pore residue.
1996,
Pubmed Luo,
Differential regulation of single CFTR channels by PP2C, PP2A, and other phosphatases.
1998,
Pubmed Mathews,
Dibasic protein kinase A sites regulate bursting rate and nucleotide sensitivity of the cystic fibrosis transmembrane conductance regulator chloride channel.
1998,
Pubmed McCarty,
Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl- channel by two closely related arylaminobenzoates.
1993,
Pubmed
,
Xenbase McCarty,
Permeation through the CFTR chloride channel.
2000,
Pubmed McDonough,
Novel pore-lining residues in CFTR that govern permeation and open-channel block.
1994,
Pubmed McNicholas,
Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator.
1996,
Pubmed
,
Xenbase Mehnert,
[Glybenclamide (HB 419): a new oral antidiabetic agent of the sulfonylurea group].
1969,
Pubmed Mikhailov,
Molecular structure of the glibenclamide binding site of the beta-cell K(ATP) channel.
2001,
Pubmed Neher,
Local anaesthetics transiently block currents through single acetylcholine-receptor channels.
1978,
Pubmed Ogden,
Ion channel block by acetylcholine, carbachol and suberyldicholine at the frog neuromuscular junction.
1985,
Pubmed Okuno,
Effect of tolbutamide and glyburide on cAMP-dependent protein kinase activity in rat liver cytosol.
1988,
Pubmed Quick,
Incubation with horse serum increases viability and decreases background neurotransmitter uptake in Xenopus oocytes.
1992,
Pubmed
,
Xenbase Rabe,
Cl- channel inhibition by glibenclamide is not specific for the CFTR-type Cl- channel.
1995,
Pubmed Riordan,
Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
1989,
Pubmed Schultz,
Glibenclamide blockade of CFTR chloride channels.
1996,
Pubmed Schwiebert,
CFTR is a conductance regulator as well as a chloride channel.
1999,
Pubmed Sheppard,
Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents.
1992,
Pubmed Sheppard,
Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- channels expressed in a murine cell line.
1997,
Pubmed Sturgess,
The sulphonylurea receptor may be an ATP-sensitive potassium channel.
1985,
Pubmed Walsh,
Structural and ionic determinants of 5-nitro-2-(3-phenylprophyl-amino)-benzoic acid block of the CFTR chloride channel.
1999,
Pubmed
,
Xenbase Weinreich,
Dual effects of ADP and adenylylimidodiphosphate on CFTR channel kinetics show binding to two different nucleotide binding sites.
1999,
Pubmed
,
Xenbase Winter,
Effect of ATP concentration on CFTR Cl- channels: a kinetic analysis of channel regulation.
1994,
Pubmed Woodhull,
Ionic blockage of sodium channels in nerve.
1973,
Pubmed Yamazaki,
Inhibitory effects of glibenclamide on cystic fibrosis transmembrane regulator, swelling-activated, and Ca(2+)-activated Cl- channels in mammalian cardiac myocytes.
1997,
Pubmed Zeltwanger,
Gating of cystic fibrosis transmembrane conductance regulator chloride channels by adenosine triphosphate hydrolysis. Quantitative analysis of a cyclic gating scheme.
1999,
Pubmed Zhang,
Voltage-sensitive gating induced by a mutation in the fifth transmembrane domain of CFTR.
2002,
Pubmed
,
Xenbase Zhang,
Direct comparison of NPPB and DPC as probes of CFTR expressed in Xenopus oocytes.
2000,
Pubmed
,
Xenbase Zhou,
Voltage-dependent flickery block of an open cystic fibrosis transmembrane conductance regulator (CFTR) channel pore.
2001,
Pubmed Zhou,
Probing an open CFTR pore with organic anion blockers.
2002,
Pubmed Zhu,
Association of cystic fibrosis transmembrane conductance regulator and protein phosphatase 2C.
1999,
Pubmed
